Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 2007

View Archived Issues

Novartis discovers a potent NPM-ALK kinase inhibitor

Hivenyl significantly reduces atopic dermatitis itch severity without sedation

VASTox joins European consortium to research new treatments for cancer

Pivotal study evaluates Aastrom's TRCs for osteonecrosis of the femoral head

Cervarix compared to Gardasil in new phase III study

Archemix and Merck KGaA sign aptamer agreement in cancer

FDA grants orphan drug status to VQD-001 for cutaneous leishmaniasis

Two phase I trials cleared to begin for Lymphoseek in prostate and colon cancers

Positive preclinical results with Endocyte's folate receptor-targeted immunotherapy

Lipsovir cold sore program makes progress

1207 shows no clear anesthetic effect in phase I study

Butyrylcholinesterase studied as chemical defense product in new phase I trial

Adherex acquires GSK's options to eniluracil

Enrollment completed in study of AZ-004 in agitated schizophrenic patients

Data on nitroflurbiprofen sets stage for clinical trials in DMD

Neuroprotection by humanin and one of its derivatives: an update

INNO-406 found effective in animal models of CNS Ph+ leukemia

Alimta launched in Japan for malignant pleural mesothelioma

Cipralex approved in Europe for OC

Full European approval for Sutent in advanced renal cell carcinoma

New therapeutic agents for ocular disorders disclosed in recent patent literature

Recent patents report novel analgesic agents

New agents for treating gastrointestinal disorders disclosed in recent patents

Inovelon approved in E.U. for Lennox-Gastaut syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...